Segall Bryant & Hamill, LLC Insmed Inc Transaction History
Segall Bryant & Hamill, LLC
- $7.07 Billion
- Q4 2024
A detailed history of Segall Bryant & Hamill, LLC transactions in Insmed Inc stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 139,045 shares of INSM stock, worth $11.1 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
139,045
Previous 140,915
1.33%
Holding current value
$11.1 Million
Previous $10.3 Million
6.68%
% of portfolio
0.14%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding INSM
# of Institutions
483Shares Held
185MCall Options Held
2.17MPut Options Held
3.25M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.46 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.14 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$1.01 Billion0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$839 Million62.32% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$521 Million0.09% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.8B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...